Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 22Prostatic Neoplasms 11Osteoporosis 8Vitamin D Deficiency 7Polycystic Ovary Syndrome 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Colonic Neoplasms 5Neoplasms 4Obesity 3Neoplasm Metastasis 3Lung Neoplasms 3Inflammation 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Bone Diseases, Metabolic 3Multiple Endocrine Neoplasia Type 1 2Motor Activity 2Lymphoma 2Leukemia 2Leiomyoma 2Giant Cell Tumor of Bone 2Gastrointestinal Neoplasms 2Cardiovascular Diseases 2Carcinoma, Transitional Cell 2Brain Neoplasms 2Bone Diseases 2Warts 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

teriflunomide 1Vitamin D 1Natalizumab 1Interferon beta-1b 1Fingolimod Hydrochloride 1Dimethyl Fumarate 1Cholecalciferol 1Calcifediol 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Sclerosis, Relapsing-Remitting × Vitamin D × Clear all
NCT05340985 2022-04-22

Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis

Tehran University of Medical Sciences

Phase 4 Unknown
54 enrolled
LymphoidOther hematologic neoplasm

Multiple Sclerosis, Relapsing-Remitting, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡